United States
Germany
Japan
United Kingdom
China
CNY 10,260.00
3周
PIK3CA Mutant (A1066V), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | A1066V |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Products
CNY 10,260.00
3周
PIK3CA Mutant (N345K), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | N345K |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (Q546L), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | Q546L |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (H1047Y), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | H1047Y |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (M1004I), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | M1004I |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (R1023Q), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | R1023Q |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (N1068fs*4), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | N1068fs*4 |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (C901F), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | C901F |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (G1007R), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | G1007R |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (R93W), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | R93W |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (T1025T), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | T1025T |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 3,990.00
2周
PIK3CA mouse monoclonal antibody, clone OTI7A7 (formerly 7A7), HRP conjugated
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
CNY 3,990.00
2周
PIK3CA mouse monoclonal antibody, clone OTI7A7 (formerly 7A7), Biotinylated
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
CNY 14,296.00
现货
Lenti ORF clone of Human phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA), Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK |
- LentiORF®
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Lentivirus
Vectors
Conjugates
Isotypes
Clonalities
Families
Pathways
- Acute myeloid leukemia (98)
- Apoptosis (98)
- B cell receptor signaling pathway (98)
- Chemokine signaling pathway (98)
- Chronic myeloid leukemia (98)
- Colorectal cancer (98)
- Endometrial cancer (98)
- ErbB signaling pathway (98)
- Fc epsilon RI signaling pathway (98)
- Fc gamma R-mediated phagocytosis (98)
- Focal adhesion (98)
- Glioma (98)
- Inositol phosphate metabolism (98)
- Insulin signaling pathway (98)
- Jak-STAT signaling pathway (98)
- Leukocyte transendothelial migration (98)
- Melanoma (98)
- Natural killer cell mediated cytotoxicity (98)
- Neurotrophin signaling pathway (98)
- Non-small cell lung cancer (98)
- Pancreatic cancer (98)
- Pathways in cancer (98)
- Phosphatidylinositol signaling system (98)
- Progesterone-mediated oocyte maturation (98)
- Prostate cancer (98)
- Regulation of actin cytoskeleton (98)
- Renal cell carcinoma (98)
- Small cell lung cancer (98)
- T cell receptor signaling pathway (98)
- Toll-like receptor signaling pathway (98)
- Type II diabetes mellitus (98)
- VEGF signaling pathway (98)
- mTOR signaling pathway (98)
